Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030

Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030


Decaffeinated Coffee Market Growth & Trends

The global decaffeinated coffee market size is estimated to reach USD 3.28 billion by 2030, registering a CAGR of 5.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising awareness about the harmful effects of caffeine on human health, such as anxiety, insomnia, digestive issues, muscle breakdown, high blood pressure, and fatigue, is expected to promote the scope of decaf coffee as healthy drinks. Additionally, shifting inclination towards functional and decaffeinated beverages among millennials at the global level as a result of increased health awareness through social media and television campaigns by hot beverage companies is expected to expand the industry scope.

Over the past few years, new product developments through synergizing the business expertise between two or three companies are expected to open new avenues. For instance, in February 2020, Starbucks and Nestlé together launched a new range of coffee capsules for the Nespresso original system. It comes in four premium signature blends and is made from ethically sourced Arabica coffee. Starbucks Decaf Espresso Roast, which is one of the four blends, has caramelly sweetness. These capsules are made from recyclable aluminum and are accepted in Nespresso’s Canadian recycling solutions.

Similarly, in February 2020, The Caffeinery's began its coffee roasting program. The roaster roasts three pounds of coffee every nine minutes. The company also offers decaffeinated blend, which has been awarded several times for its year-round catalog. Likewise, in January 2020, McDonald’s through its brand, McCafe launched decaf coffee drinks with the aim of attracting local customers who are sensitive to caffeine and heavy coffee drinkers. Four such drinks are available, which include Americano, McCafe Latte, Cappuccino, and Espresso. This offers a variety of choices for customers seeking to control their daily caffeine intake.

Key decaffeinated coffee market participants include SWISS WATER DECAFFEINATED COFFEE INC.; LifeBoost Decaf; Cafe Don Pablo Colombia Supremo Decaf; No Fun Jo Decaf; and Fresh Roasted. Product innovation is expected to remain a key strategy among the industry players in the near future.

Decaffeinated Coffee Market Report Highlights
  • Roasted products are expected to expand at the higest CAGR over the forecast period. These product categories are expected to gain popularity among the consumers due to their enhanced flavor and excellent aroma characteristics
  • Based on bean species, Arabica segment dominated the market with the largest revenue share in 2024. This is attributed to large cultivation and easy availability of these beans
  • Asia Pacific decaffeinated coffee market is expected to exhibit the fastest CAGR of 6.4% from 2025 to 2030, on account of improvement in economic indicators in countries, including Indonesia, Malaysia, and India.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of target disease
3.2.1.2. Growing demand for point-of-care tests
3.2.1.3. Implementation of favorable government initiatives & external funding for R&D activities
3.2.1.4. Introduction of CLIA waived tests
3.2.1.5. Rising demand for early disease detection
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory and reimbursement policies
3.2.2.2. Limitations associated with blood testing
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Collection Site Business Analysis
4.1. Blood Testing Market: Collection Site Dashboard
4.2. Blood Testing Market: Collection Site Movement Analysis
4.3. Blood Testing Market by Collection Site, Revenue
4.4. Glucose Testing
4.4.1. Glucose Testing Market, 2018 - 2030 (USD Million)
4.5. A1C Testing
4.5.1. A1C Testing Market, 2018 - 2030 (USD Million)
4.6. Direct LDL Testing
4.6.1. Direct LDL Testing Market, 2018 - 2030 (USD Million)
4.7. Lipid Panel Testing
4.7.1. Lipid Panel Testing Market, 2018 - 2030 (USD Million)
4.8. Prostate Specific Antigen Testing
4.8.1. Prostate Specific Antigen Testing Market, 2018 - 2030 (USD Million)
4.9. COVID-19 Testing
4.9.1. COVID-19 Testing Market, 2018 - 2030 (USD Million)
4.10. BUN Testing
4.10.1. BUN Testing Market, 2018 - 2030 (USD Million)
4.11. Vitamin D Testing
4.11.1. Vitamin D Testing Market, 2018 - 2030 (USD Million)
4.12. Thyroid Stimulating Hormone (TSH) Testing
4.12.1. Thyroid Stimulating Hormone (TSH) Testing Market, 2018 - 2030 (USD Million)
4.13. Serum Nicotine/Cotinine Testing
4.13.1. Serum Nicotine/Cotinine Testing Market, 2018 - 2030 (USD Million)
4.14. High Sensitivity CRP Testing
4.14.1. High Sensitivity CRP Testing Market, 2018 - 2030 (USD Million)
4.15. Testosterone Testing
4.15.1. Testosterone Testing Market, 2018 - 2030 (USD Million)
4.16. ALT Testing
4.16.1. ALT Testing Market, 2018 - 2030 (USD Million)
4.17. Cortisol Testing
4.17.1. Cortisol Testing Market, 2018 - 2030 (USD Million)
4.18. Creatinine Testing
4.18.1. Creatinine Testing Market, 2018 - 2030 (USD Million)
4.19. AST Testing
4.19.1. AST Testing Market, 2018 - 2030 (USD Million)
4.20. Other Blood Tests
4.20.1. Other Blood Tests Market, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
5.1. Blood Testing Market Share By Region, 2024 & 2030
5.2. North America
5.2.1. North America Blood Testing Market, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. Key Country Dynamics
5.2.2.2. Competitive Scenario
5.2.2.3. Regulatory Framework
5.2.2.4. U.S. Blood Testing Market, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Key Country Dynamics
5.2.3.2. Competitive Scenario
5.2.3.3. Regulatory Framework
5.2.3.4. Canada Blood Testing Market, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Key Country Dynamics
5.2.4.2. Competitive Scenario
5.2.4.3. Regulatory Framework
5.2.4.4. Mexico Blood Testing Market, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Blood Testing Market, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. Key Country Dynamics
5.3.2.2. Competitive Scenario
5.3.2.3. Regulatory Framework
5.3.2.4. UK Blood Testing Market, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Framework
5.3.3.4. Germany Blood Testing Market, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Framework
5.3.4.4. France Blood Testing Market, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Key Country Dynamics
5.3.5.2. Competitive Scenario
5.3.5.3. Regulatory Framework
5.3.5.4. Italy Blood Testing Market, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Key Country Dynamics
5.3.6.2. Competitive Scenario
5.3.6.3. Regulatory Framework
5.3.6.4. Spain Blood Testing Market, 2018 - 2030 (USD Million)
5.3.7. Sweden
5.3.7.1. Key Country Dynamics
5.3.7.2. Competitive Scenario
5.3.7.3. Regulatory Framework
5.3.7.4. Sweden Blood Testing Market, 2018 - 2030 (USD Million)
5.3.8. Norway
5.3.8.1. Key Country Dynamics
5.3.8.2. Competitive Scenario
5.3.8.3. Regulatory Framework
5.3.8.4. Norway Blood Testing Market, 2018 - 2030 (USD Million)
5.3.9. Denmark
5.3.9.1. Key Country Dynamics
5.3.9.2. Competitive Scenario
5.3.9.3. Regulatory Framework
5.3.9.4. Denmark Blood Testing Market, 2018 - 2030 (USD Million)
5.3.10. Russia
5.3.10.1. Key Country Dynamics
5.3.10.2. Competitive Scenario
5.3.10.3. Regulatory Framework
5.3.10.4. Russia Blood Testing Market, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Blood Testing Market, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Framework
5.4.2.4. China Blood Testing Market, 2018 - 2030 (USD Million)
5.4.3. India
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. India Blood Testing Market, 2018 - 2030 (USD Million)
5.4.4. Japan
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. Japan Blood Testing Market, 2018 - 2030 (USD Million)
5.4.5. Thailand
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Framework
5.4.5.4. Thailand Blood Testing Market, 2018 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Framework
5.4.6.4. South Korea Blood Testing Market, 2018 - 2030 (USD Million)
5.4.7. Singapore
5.4.7.1. Key Country Dynamics
5.4.7.2. Competitive Scenario
5.4.7.3. Regulatory Framework
5.4.7.4. Singapore Blood Testing Market, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Blood Testing Market, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Brazil Blood Testing Market, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. Argentina Blood Testing Market, 2018 - 2030 (USD Million)
5.6. MEA
5.6.1. MEA Blood Testing Market, 2018 - 2030 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. Saudi Arabia Blood Testing Market, 2018 - 2030 (USD Million)
5.6.3. South Africa
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. South Africa Blood Testing Market, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. UAE Blood Testing Market, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. Kuwait Blood Testing Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2024
6.4. Company Profiles/Listing
6.4.1. Abbott
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Collection Site Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. bioMerieux
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Collection Site Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Quest Diagnostics Incorporated
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Collection Site Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Biomerica, Inc
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Collection Site Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. BD
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Collection Site Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. QIAGEN Siemens Healthineers AG
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Collection Site Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Danaher Corporation
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Collection Site Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Trinity Biotech Plc
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Collection Site Benchmarking
6.4.8.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings